Asthma and COPD: Comparison with International Guidelines and Medication Adherence in Belgium
Asthma and chronic obstructive pulmonary disease (COPD) are major chronic conditions. It is possible to limit their impact by controlling symptoms, which limits exacerbations and worsening of the disease, by choosing the appropriate treatment and ensuring that the patient adheres to it. The main pur...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2023-07-01
|
| Series: | Pharmaceuticals |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1424-8247/16/7/1030 |
| _version_ | 1797587841399652352 |
|---|---|
| author | Natacha Biset Mélanie Lelubre Stéphanie Pochet Carine De Vriese |
| author_facet | Natacha Biset Mélanie Lelubre Stéphanie Pochet Carine De Vriese |
| author_sort | Natacha Biset |
| collection | DOAJ |
| description | Asthma and chronic obstructive pulmonary disease (COPD) are major chronic conditions. It is possible to limit their impact by controlling symptoms, which limits exacerbations and worsening of the disease, by choosing the appropriate treatment and ensuring that the patient adheres to it. The main purpose of this study was to assess medication adherence and persistence with inhaled medications for chronic treatment of asthma and COPD, as well as to evaluate the factors influencing this adherence. Medication adherence was measured from January 2013 to December 2016 using continuous multiple-interval measures of medication availability (CMA). Persistence was evaluated by treatment episodes (TE). We analyzed the influence of different factors on CMA such as sex, age, type of device, and the realization of the “new medicines service” (NMS), introduced in Belgium in October 2013 to support patients in adhering to their treatment. We also analyzed the consumption of these inhaled medications within the Belgian population and compared them with the Global Initiative for Asthma (GINA) and the Global Initiative for Chronic Obstructive Lung Disease (GOLD) recommendations. Medication adherence varied greatly between the different pharmacological classes: inhaled corticosteroids (ICS) alone or in combination with long-acting beta agonists (LABA) had the lowest medication adherence and persistence, while adherence was highest for the long-acting muscarinic antagonists (LAMA) and LABA/LAMA associations. The NMS seemed to have a positive impact on medication adherence, although few patients completed the two guidance interviews offered by the service. In addition, only a minority of the targeted patients took advantage of this new service. |
| first_indexed | 2024-03-11T00:44:33Z |
| format | Article |
| id | doaj.art-10b96c95ee434054be2c1aabd466c4b0 |
| institution | Directory Open Access Journal |
| issn | 1424-8247 |
| language | English |
| last_indexed | 2024-03-11T00:44:33Z |
| publishDate | 2023-07-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Pharmaceuticals |
| spelling | doaj.art-10b96c95ee434054be2c1aabd466c4b02023-11-18T20:53:24ZengMDPI AGPharmaceuticals1424-82472023-07-01167103010.3390/ph16071030Asthma and COPD: Comparison with International Guidelines and Medication Adherence in BelgiumNatacha Biset0Mélanie Lelubre1Stéphanie Pochet2Carine De Vriese3Department of Pharmacotherapy and Pharmaceutics, Faculty of Pharmacy, Université Libre de Bruxelles (ULB), 1050 Brussels, BelgiumDepartment of Pharmacotherapy and Pharmaceutics, Faculty of Pharmacy, Université Libre de Bruxelles (ULB), 1050 Brussels, BelgiumDepartment of Pharmacotherapy and Pharmaceutics, Faculty of Pharmacy, Université Libre de Bruxelles (ULB), 1050 Brussels, BelgiumDepartment of Pharmacotherapy and Pharmaceutics, Faculty of Pharmacy, Université Libre de Bruxelles (ULB), 1050 Brussels, BelgiumAsthma and chronic obstructive pulmonary disease (COPD) are major chronic conditions. It is possible to limit their impact by controlling symptoms, which limits exacerbations and worsening of the disease, by choosing the appropriate treatment and ensuring that the patient adheres to it. The main purpose of this study was to assess medication adherence and persistence with inhaled medications for chronic treatment of asthma and COPD, as well as to evaluate the factors influencing this adherence. Medication adherence was measured from January 2013 to December 2016 using continuous multiple-interval measures of medication availability (CMA). Persistence was evaluated by treatment episodes (TE). We analyzed the influence of different factors on CMA such as sex, age, type of device, and the realization of the “new medicines service” (NMS), introduced in Belgium in October 2013 to support patients in adhering to their treatment. We also analyzed the consumption of these inhaled medications within the Belgian population and compared them with the Global Initiative for Asthma (GINA) and the Global Initiative for Chronic Obstructive Lung Disease (GOLD) recommendations. Medication adherence varied greatly between the different pharmacological classes: inhaled corticosteroids (ICS) alone or in combination with long-acting beta agonists (LABA) had the lowest medication adherence and persistence, while adherence was highest for the long-acting muscarinic antagonists (LAMA) and LABA/LAMA associations. The NMS seemed to have a positive impact on medication adherence, although few patients completed the two guidance interviews offered by the service. In addition, only a minority of the targeted patients took advantage of this new service.https://www.mdpi.com/1424-8247/16/7/1030medication adherenceinhaled treatmentasthmaCOPDnew medicines service |
| spellingShingle | Natacha Biset Mélanie Lelubre Stéphanie Pochet Carine De Vriese Asthma and COPD: Comparison with International Guidelines and Medication Adherence in Belgium Pharmaceuticals medication adherence inhaled treatment asthma COPD new medicines service |
| title | Asthma and COPD: Comparison with International Guidelines and Medication Adherence in Belgium |
| title_full | Asthma and COPD: Comparison with International Guidelines and Medication Adherence in Belgium |
| title_fullStr | Asthma and COPD: Comparison with International Guidelines and Medication Adherence in Belgium |
| title_full_unstemmed | Asthma and COPD: Comparison with International Guidelines and Medication Adherence in Belgium |
| title_short | Asthma and COPD: Comparison with International Guidelines and Medication Adherence in Belgium |
| title_sort | asthma and copd comparison with international guidelines and medication adherence in belgium |
| topic | medication adherence inhaled treatment asthma COPD new medicines service |
| url | https://www.mdpi.com/1424-8247/16/7/1030 |
| work_keys_str_mv | AT natachabiset asthmaandcopdcomparisonwithinternationalguidelinesandmedicationadherenceinbelgium AT melanielelubre asthmaandcopdcomparisonwithinternationalguidelinesandmedicationadherenceinbelgium AT stephaniepochet asthmaandcopdcomparisonwithinternationalguidelinesandmedicationadherenceinbelgium AT carinedevriese asthmaandcopdcomparisonwithinternationalguidelinesandmedicationadherenceinbelgium |